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the association between frailty 
and MRi features of cerebral small 
vessel disease
ilse M. J. Kant1,2, Henri J. M. M. Mutsaerts  2, Simone J. T. van Montfort1, Myriam G. Jaarsma-
coes3, Theodoor D. Witkamp2, Georg Winterer4,5,6, Claudia D. Spies  6, Jeroen Hendrikse2, 
Arjen J. c. Slooter1, Jeroen de Bresser  2,3 & the BioCog Consortium*
Frailty is a common syndrome in older individuals that is associated with poor cognitive outcome. The 
underlying brain correlates of frailty are unclear. The aim of this study was to investigate the association 
between frailty and MRI features of cerebral small vessel disease in a group of non-demented older 
individuals. We included 170 participants who were classified as frail (n = 30), pre-frail (n = 85) or non-
frail (n = 55). The association of frailty and white matter hyperintensity volume and shape features, 
lacunar infarcts and cerebral perfusion was investigated by regression analyses adjusted for age and 
sex. Frail and pre-frail participants were older, more often female and showed higher white matter 
hyperintensity volume (0.69 [95%-CI 0.08 to 1.31], p = 0.03 respectively 0.43 [95%-CI: 0.04 to 0.82], 
p = 0.03) compared to non-frail participants. Frail participants showed a non-significant trend, and 
pre-frail participants showed a more complex shape of white matter hyperintensities (concavity index: 
0.04 [95%-CI: 0.03 to 0.08], p = 0.03; fractal dimensions: 0.07 [95%-CI: 0.00 to 0.15], p = 0.05) compared 
to non-frail participants. No between group differences were found in gray matter perfusion or in the 
presence of lacunar infarcts. In conclusion, increased white matter hyperintensity volume and a more 
complex white matter hyperintensity shape may be structural brain correlates of the frailty phenotype.
Frailty is a chronic condition of increased vulnerability to physiological stressors that is common in older indi-
viduals and is most often described using the physical frailty phenotype1–3. Frail older individuals have a higher 
risk of falling, postoperative complications, dependency and cognitive decline, compared to non-frail counter-
parts1,4,5. The impact of these consequences of frailty on a societal and economic level in an aging population 
stresses the importance of investigating the pathways leading to a frail condition. To date, the biological pathways 
leading to the decline of multiple physiological systems remain unknown. The association between frailty and 
cognitive disorders suggests a structural brain correlate, but this is currently largely unknown.
Cerebral small vessel disease (SVD) is a syndrome that is characterized by manifestations of diseases of the 
small vessels in the brain, with probably different underlying pathophysiology and etiology6,7. SVD is one of the 
major causes of stroke, cognitive decline and dementia in older individuals6,8. The most commonly used MRI 
features of SVD are white matter hyperintensity of presumed vascular origin (WMH) volume and the presence 
of lacunar infarcts6,9.
Previous studies on the association between of frailty with WMH volume or lacunar infarcts have shown 
inconsistent results10–16. Due to the heterogeneous nature of SVD, other MRI features of SVD may provide addi-
tional information17–20. Recent studies have shown that WMH shape is a novel promising feature related to more 
severe small vessel changes19,20. Furthermore, cerebral perfusion measured by arterial spin labeling (ASL) MRI 
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could detect early hemodynamic changes that may be related to SVD21–23. Frailty may therefore be associated with 
both structural brain changes of SVD as well as quantitative hemodynamic changes.
The aim of this study was to investigate the association between frailty and MRI features of cerebral SVD in 
a group of non-demented older individuals who were scheduled for major elective surgery. We assessed both 
commonly used structural features (WMH volume and presence of lacunar infarcts) and novel structural (WMH 
shape) and hemodynamic features (cerebral perfusion) of cerebral SVD.
Results
Of the 178 participants that completed the MRI scanning protocol, a total of 8 participants had to be excluded 
from all analyses, due to extremely large ventricles that hindered accurate segmentation (n = 1), an incomplete 
FLAIR and ASL sequence (n = 1), or major MRI artifacts (e.g. motion; n = 6), leaving 170 participants for the 
current study. Demographics for frail (n = 30), pre-frail (n = 85) and non-frail (n = 55) participants are shown in 
Table 1. Frail participants were older, more often female, had higher ASA classification scores and a higher body 
mass index (BMI) compared to pre- and non-frail individuals. No between-group differences in other vascular 
risk factors or MMSE scores were found. A total of 13 participants had to be excluded from the WMH feature 
analyses due to major segmentation errors (n = 6), FLAIR artifacts (e.g. motion, n = 4) or no availability of a 
FLAIR sequence (n = 2). A total of 90 participants had an ASL image of sufficient quality for perfusion analysis, 
and a total of 156 participants had an ASL image that could be used for spatial CoV analysis of vascular signal.
WMH volume. Frail participants showed a higher total (0.69 [95% CI 0.08 to 1.31]), p = 0.03 and periven-
tricular/confluent (0.67 [95% CI 0.06 to 1.30], p = 0.03) natural log transformed WMH volume compared to 
non-frail participants (see Table 2). Pre-frail participants showed also a higher total natural log transformed 
WMH volume (0.43 [95% CI 0.04 to 0.81], p = 0.03) and a higher periventricular and confluent natural log trans-
formed WMH volume (0.43 [95% CI 0.04 to 0.81], p = 0.03) than non-frail participants.
presence of lacunar infarcts. In total, 20% (n = 6) of the frail participants, 27% (n = 23) of the pre-frail 
participants and 22% (n = 12) of the non-frail participants had lacunar infarcts. Logistic regression analyses cor-
rected for age and sex showed no between-group differences in the presence of lacunar infarcts (frail versus 
non-frail: OR (95% CI) = 1.25 [0.35 to 4.42], p = 0.73; pre-frail versus non-frail: OR (95% CI) = 1.35 [0.59 to 
3.08], p = 0.48).
Frail (n = 30) Pre-frail (n = 85)
Non-frail 
(n = 55) p-value
Age 74 ± 5 72 ± 5 70 ± 4 0.01
Female gender 16 (53%) 24 (28%) 12 (22%) 0.01
MMSE 28 (28, 29) 29 (27, 30) 29 (28, 30) 0.81
Depressive symptoms 4 (13%) 6 (7%) 1 (2%) 0.12
ASA score 0.04
   I 1 (3%) 8 (9%) 11 (20%)
   II 15 (50%) 45 (53%) 32 (58%)
   III 14 (47%) 32 (38%) 12 (22%)
Vascular risk factors
   Diabetes 8 (27%) 12 (14%) 6 (11%) 0.13
   BMI 29 ± 6 27 ± 4 26 ± 4 0.01
   Obesity 9 (30%) 19 (22%) 6 (11%) 0.08
   Hypertension 17 (57%) 45 (53%) 22 (40%) 0.21
   Hyperlipidemia 12 (40%) 36 (42%) 16 (29%) 0.28
   Current smoker 3 (10%) 8 (10%) 3 (5%) 0.60
   TIA/CVA 3 (10%) 5 (6%) 1 (2%) 0.10
Frailty components
   Slowness 23 (77%) 18 (21%) — n/a
   Weakness 18 (60%) 27 (32%) —
   Weight loss 11 (37%) 19 (22%) —
   Exhaustion 24 (80%) 22 (26%) —
   Mobility 27 (90%) 34 (40%) —
Table 1. Demographics. Note. Data represent n (percentage), mean ± SD or median (interquartile range). A 
one-way ANOVA comparison of three groups was performed on continuous data. A chi-square comparison of 
three groups was performed for categorical data. MMSE: mini-mental state exam. ASA: classification of disease 
severity for the American Society of Anesthesiologists. BMI: body-mass index. TIA: transient ischemic attack. 
CVA: cerebrovascular accident.
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WMH shape features. Frail participants showed a non-significant trend for a more complex shape 
of periventricular and confluent WMH (concavity index (0.05 [95% CI 0.00 to 0.11], p = 0.06) compared to 
non-frail participants (see Table 3). Pre-frail participants showed a more complex shape of periventricular and 
confluent WMH (a higher concavity index of 0.04 [95% CI 0.03 to 0.08], p = 0.03 and a higher fractal dimension 
of 0.07 [95% CI 0.00 to 0.15], p = 0.05) compared to non-frail participants (see Table 3). No between-group dif-
ferences were found in shape features of deep WMH (eccentricity and fractal dimensions). In secondary analyses, 
the between group differences in the shape of periventricular and confluent WMH attenuated after additional 
correction for natural log transformed WMH volume, indicating that these differences were also partly explained 
by WMH volume (see supplementary Table B).
perfusion. Analysis of global cerebral perfusion of gray matter and white matter showed no significant dif-
ferences between frail and non-frail participants, and no significant differences between pre-frail and non-frail 
participants. Furthermore, no between group differences were found in spatial CoV of the perfusion images (see 
Table 4).
Exploratory analysis of relevant MRI features of SVD per frailty component. Exploratory anal-
yses were performed of the MRI features of SVD that showed between-group differences (total WMH volume, 
concavity index, fractal dimensions), see Supplementary Table C. The physical frailty component slowness 
showed an association with WMH volume (0.65 [95% CI 0.23 to 1.06], p = 0.003) and with a more complex shape 
of WMH (fractal dimensions: 0.12 [95% CI 0.04 to 0.21], p = 0.003). The component exhaustion also showed a 
relation with WMH volume (0.41 [95% CI 0.00 to 0.82], p = 0.048). Other physical frailty components (weakness, 
weight loss, mobility) showed no significant association with the studied SVD features.
Discussion
In summary, we observed that frail and pre-frail participants had a higher WMH volume compared to non-frail 
participants. Furthermore, pre-frail participants showed a more complex shape of periventricular and confluent 
WMH compared to non-frail participants. No between group differences were found in shape features of deep 
WMH, cerebral perfusion or presence of lacunar infarcts.
Previous community-based studies showed an inconsistent association between frailty and WMH volume 
and lacunar infarcts10–16. Direct comparison with these studies is however hindered by the use of different meth-
ods to assess frailty. The frailty assessment of these studies differed between the physical frailty phenotype by 
Fried et al.11,12,14–16, and frailty scores that included measures of cognition, such as the Edmonton Frail Scale or 
the frailty index2,10,13,24. Four of the previous studies that assessed WMH showed an association between WMH 
and frailty10,11,15,16, three other studies that were performed only found a weak or no association12–14. Almost all 
Frail (n = 28)
Pre-frail 
(n = 77)
Non-frail 
(n = 52) Frail vs. non-frail Pre-frail vs. non-frail
Total WMH 
volume 10.92 ± 15.80 8.68 ± 11.28 4.89 ± 7.38 0.69 (0.08, 1.31)* 0.43 (0.04, 0.82)*
Periventricular 
and confluent 
WMH volume
10.52 ± 15.68 8.32 ± 11.09 4.64 ± 7.13 0.67 (0.06, 1.3)* 0.43 (0.04, 0.81)*
Deep WMH 
volume 0.40 ± 0.66 0.36 ± 0.65 0.25 ± 0.49 0.55 (−0.35, 1.46) 0.27 (−0.34, 0.87)
Table 2. The association between physical frailty and WMH volume. Note. Data are represented as mean 
WMH volume (ml) ± SD. The linear regression analyses were adjusted for age, gender and ICV. Regression beta 
coefficients are presented with a 95% confidence interval. WMH volumes were multiplied by 100 and natural 
log transformed before performing regression analyses. *p = 0.03.
Frail (n = 28)
Pre-frail 
(n = 77)
Non-frail 
(n = 52) Frail vs. non-frail Pre-frail vs. non-frail
Periventricular/confluent WMH
Soliditya 0.29 ± 0.18 0.31 ± 0.20 0.36 ± 0.20 −0.14 (−0.43, 0.15) −0.16 (−0.37, 0.04)
Convexity 1.15 ± 0.18 1.14 ± 0.18 1.17 ± 0.17 −0.04 (−0.13, 0.05) −0.02 (−0.08, 0.05)
Concavity index 1.13 ± 0.13 1.13 ± 0.24 1.08 ± 0.09 0.05 (0.00, 0.11) 0.04 (0.03, 0.08)*
Fractal dimension 1.68 ± 0.26 1.67 ± 0.22 1.57 ± 0.22 0.08 (−0.03, 0.20) 0.07 (0.00, 0.15)*
Deep WMH
Eccentricity 0.58 ± 0.15 0.56 ± 0.18 0.58 ± 0.10 0.01 (−0.06, 0.08) −0.01 (−0.08, 0.05)
Fractal dimension 1.83 ± 0.20 1.81 ± 0.35 1.88 ± 0.23 −0.04 (−0.17, 0.09) −0.06 (−0.19, 0.07)
Table 3. The association between physical frailty and WMH shape features. Note. Data are represented as 
means ± SD. Regression analysis were adjusted for age and gender. Regression beta coefficients are presented 
with a 95% confidence interval. aSolidity was multiplied by 100 and natural log transformed. *Concavity index: 
p = 0.03, Fractal dimension: p = 0.05.
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previous studies were community-based studies performed in older adults10–13,15,16, although the studies that did 
not find an association included slightly younger individuals, possibly explaining the different findings12,13. Our 
study adds to the body of evidence for an association between frailty and WMH volume10,12,15.
Comparison of previous studies regarding the association between frailty and lacunar infarcts is difficult due 
to use of different definitions of lacunar infarcts. Most previous studies did not conform with the size definition of 
lacunar infarcts (3–15 mm) according to the internationally accepted guidelines that we used on MRI markers of 
small vessel disease proposed in the STRIVE criteria25. One previous study found an association between frailty 
and cerebral infarcts >3 mm15, whereas another earlier study showed no association with a frailty score that 
included cognitive tests and infarcts <20 mm10. Another previous study that investigated the relation between 
physical performance (e.g. gait, walking speed) and lacunar infarcts in memory clinic patients showed no relation 
between impaired physical performance and the presence of lacunar infarcts according to the STRIVE criteria26. 
Our findings are in accordance with these previous findings, as we did not find an association between frailty and 
lacunar infarcts10. The prevalence of lacunar infarcts in our study (24% in a population with a mean age of 71 ± 5 
years of age) is comparable to the prevalence in a general older population (20% in a population with a mean age 
of 70 ± 7 years of age)27.
No previous study has been performed on the association between frailty and WMH shape features, and only 
few studies have been performed on WMH shape features in general19,20. A previous cohort study in patients with 
symptomatic atherosclerotic disease showed that the presence of lacunar infarcts was related to a more complex 
WMH shape20. Furthermore, WMH shape was different in patients with type 2 diabetes mellitus (a condition 
associated with cerebral SVD) compared to healthy individuals19. These investigations indicate that WMH shape 
may be helpful in examining the heterogeneity of cerebral SVD and that a more complex shape of WMH may 
be associated with more severe manifestations of cerebral SVD19,20. Although our study is the first to show the 
relation between frailty and a more complex shape of WMH, these associations were not completely independent 
of WMH volume. A more complex WMH shape combined with increased WMH volume could be part of the 
structural brain changes that underlie the physical frailty phenotype.
Cerebral perfusion as measured by arterial spin labeling MRI is an indicator of brain metabolism and is one 
of the early markers for cognitive deterioration. Recently it has been suggested that low perfusion is a marker for 
SVD, although it is not yet clear whether this precedes or follows the presence of WMH28. Previous cross-sectional 
studies on SVD in both demented and non-demented populations showed that a higher WMH volume is asso-
ciated with lower total CBF, although this was partly driven by co-occurrence of neurodegenerative diseases29,30. 
Our study is, to the best of our knowledge, the first that assessed the relation between global gray matter perfusion 
and frailty. We did not find an association between cerebral perfusion and physical frailty. A possible explanation 
for not finding this association may be that altered brain hemodynamics could be a marker for a more severe type 
of SVD in comparison to our population29.
No previous studies on frailty and markers of SVD additionally explored the relation between individual 
frailty components and features of SVD. However, some previous investigations were performed on separate com-
ponents without exploring overall frailty, such as gait speed31, the short physical performance battery32, mobil-
ity33, and exhaustion34. These studies all showed an association between these components and MRI markers for 
SVD31–34. In exploratory analyses in our study, all components were associated with a higher WMH volume and a 
more complex WMH shape, although only slowness and exhaustion reached statistical significance. For slowness, 
this finding is in line with previous findings on gait speed and the short physical performance battery31,32. The 
exhaustion component in our study was derived from one question of a questionnaire on anxiety and depres-
sion, and may not be accurate enough. The recommended assessment of exhaustion is by the CES-D depression 
scale, which could be more sensitive and specific to exhaustion35. A possible explanation for the relation between 
exhaustion and WMH volume might be that exhausted participants were slightly more depressed, which has pre-
viously been related to a higher WMH volume33. As this was a secondary analysis and there is not much previous 
evidence, these results should be carefully interpreted.
Strengths of our study include the detailed assessment of both commonly used features of cerebral SVD 
(WMH volume and lacunar infarcts) and more novel features of cerebral SVD (WMH shape features and cerebral 
perfusion) together with a detailed assessment of the physical frailty phenotype. Limitations of our study could 
be the limited number of physically frail individuals, causing a difference in group size between frail, pre-frail 
and non-frail individuals. Due to these differences, we had a lower statistical power to detect differences between 
frail and non-frail individuals. This may explain why we did not find a statistically significant difference in WMH 
shape or perfusion between frail and non-frail individuals. Another limitation is that participants from our study 
Frail 
(n = 13)
Pre-frail 
(n = 40)
Non-frail 
(n = 37) Frail vs. non-frail Pre-frail vs. non-frail
Gray matter 
perfusion 97 ± 24 82 ± 17 85 ± 20 12.3 (−2.8, 27.5) −5.3 (−18.0, 7.3)
Deep WM 
perfusion 28 ± 8 26 ± 10 25 ± 8 1.3 (−4.6, 7.1) 0.7 (−3.8, 5.1)
Spatial CoVa 2.51 ± 0.70 2.52 ± 0.61 2.36 ± 0.56 0.18 (−0.16, 0.51) 0.15 (−0.07, 0.36)
Table 4. The association between physical frailty and cerebral perfusion. Note. Data are represented as 
mean ± SD. Linear regression analysis were adjusted for age and gender. Regression beta coefficients are 
presented with a 95% confidence interval. aData represents the spatial coefficient of variation of n = 15 frail, 
n = 67 pre-frail and n = 48 non-frail individuals.
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were all scheduled for major elective surgery and may not be comparable to the general population. This could 
limit the generalizability of our findings to the general population. A limitation in our assessment of slowness is 
that we did not consider comorbidities such as arthritis and pulmonary disease, which could have influenced the 
results of walking speed and exhaustion. A technical limitation could be that WMH segmentation methods in 
general have a limited accuracy for segmentation of especially smaller deep WMH. This may have underestimated 
possible associations between frailty and shape of deep WMH.
In conclusion, increased WMH volume and a more complex shape of WMH may be structural correlates of 
the physical frailty phenotype.
Methods
Study design and participants. Data were obtained from the BioCog consortium study: an international 
observational study that aims to identify biomarkers of postoperative cognitive disorders36. The BioCog study is 
performed at the Charité Universitätsmedizin Berlin and the University Medical Center Utrecht36. The present 
study uses patient data that were collected at the University Medical Center Utrecht only. Patients who were 
included in BioCog (1) were at least 65 years of age, (2) were scheduled for major elective surgery of at least 
60 minutes, and (3) had a mini-mental state exam (MMSE) score of 24 or higher. The medical ethics committee of 
both centers approved all procedures under ethical approval number EA2/092/14 (Berlin: Ethikkommission der 
Charité) and 14-469 (Utrecht: Medisch Ethische Toetsingscommissie Utrecht). All participants signed informed 
consent. All methods were performed in accordance with all relevant guidelines and regulations that apply to 
research with human participants.
procedure. Trained research personnel collected demographic data, data on vascular risk factors (i.e. ques-
tionnaires and medical history records, vascular risk factors, obesity, which was defined as a body-mass index 
of ≥3037) and administered the MMSE during a visit prior to surgery. A hospital anxiety and depression scale 
(HADS) score on the depression subscale ≥8 was seen as having depressive symptoms38. Anesthesiologists (in 
training) performed the classification for the American Society of Anesthesiologists score.
frailty assessment. Participants were classified based on five frailty components according to the Fried 
frailty phenotype2,39: slowness, weakness, weight loss, exhaustion and mobility. Slowness was measured by the 
timed up and go test40; when this took over 10 seconds it was scored as slow. Weakness was assessed by low max-
imal hand grip strength, adjusting for sex and body mass index2. Weight loss was determined by a self-reported 
unintentional weight loss of ≥5% or ≥3 kg in the previous year. Exhaustion was determined by self-reported 
exhaustion in the geriatric depression scale or the hospital anxiety and depression scale. Mobility was scored by 
a self-reported inability to walk without difficulty from the EuroQOL five dimensions questionnaire41 and the 
Barthel index42. Participants who did not show presence of any frailty components were classified as non-frail, 
those who showed presence of one or two frailty components were classified as pre-frail, and those who scored 
positive on three or more frailty components were classified as frail (see14 for more details).
MRi scans. Participants were scanned on a Philips Achieva 3T MRI scanner. The MRI scanning protocol con-
sisted of a three-dimensional (3D) T1-weighted sequence (voxel size = 1.0 × 1.0 × 1.0 mm3; TR/TE = 7.9/4.5 ms), 
a 3D fluid-attenuated inversion recovery (FLAIR) sequence (voxel size = 1.11 × 1.11 × 0.56 mm3; TR/
TE/TI = 4800/125/1650 ms), a pseudo-continuous arterial spin labeling (pCASL) sequence (voxel 
size = 3.0 × 3.0 × 7.0 mm3; TR/TE = 3919/17 ms, label duration = 1650 ms, post labeling delay = 1525 ms) and 
a diffusion-weighted image (DWI) (voxel size = 0.96 × 1.19 × 4 mm3; TR/TE = 3294/68 ms). Presence of lacunar 
infarcts was visually rated on the T1-weighted, FLAIR and DWI images by two experienced neuro-radiologists 
(JB (11 years of experience) and TW (25 years of experience)) according to the standards for reporting vascular 
changes on neuroimaging (STRIVE) criteria25.
Quantification of WMH volume and shape features. 3D FLAIR images were registered to the 
T1-weighted images using statistical parametric mapping version 12 (SPM12; Wellcome Institute of Neurology, 
University College London, UK, http://www.fil.ion.ucl.ac.uk/spm/doc/) for Matlab (The MathWorks, Inc., Natick, 
Massachusetts, United States). WMH segmentations were performed on the registered 3D FLAIR images by the 
lesion prediction algorithm (Schmidt, 2017, Chapter 6.143) of the lesion segmentation toolbox version 2.0.15 
(www.statistical-modeling.de/lst.html) for SPM12. Visual quality control for the WMH segmentations was per-
formed by a trained researcher (IK) and supervised by a neuro-radiologist (JB), see Fig. 1 for an example. Cortical 
infarcts were manually delineated by a trained researcher (IK) and removed from the WMH probability maps. 
Lateral ventricular segmentation on the T1-weighted images was performed using the automated lateral ventricle 
delineation toolbox (ALVIN) in SPM8. The probabilistic WMH segmentations were thresholded at 10%. WMH 
within 10 mm from the lateral ventricles into the white matter were considered periventricular WMH. WMH that 
extended from periventricular to more than 10 mm into the deep white matter were considered confluent WMH. 
WMH that were located >10 mm from the lateral ventricles were considered deep WMH. WMH shape features 
were calculated from the thresholded WMH segmentations20. The solidity, convexity, concavity index and fractal 
dimension of periventricular and confluent WMH were calculated by reconstruction of the convex hull, volume 
and surface area of all individual lesions. The eccentricity and fractal dimension were calculated of deep WMH 
(see20 and Supplementary Table A for more details). For all WMH shape features, mean values per feature were 
calculated per patient and used for further analyses.
CBF quantification. ASL images were processed with ExploreASL44. Lesion filling of the T1-weighted images 
was performed by the lesion segmentation toolbox version 2.0.15 (www.statistical-modeling.de/lst.html) for SPM12. 
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The filled T1-weighted images were segmented using CAT1245. CBF images were motion corrected and registered 
to the gray matter partial volume maps44. The CBF images were quantified with a single compartment model46, after 
which the mean CBF was obtained for a total gray matter perfusion and deep WM region-of-interest (ROI)47. The 
spatial coefficient of variation (spatial CoV) was calculated within the total GM as a proxy parameter of vascular suf-
ficiency (for more details see23). All perfusion images were rated as images containing (1) CBF contrast, (2) vascular 
contrast or no contrast by a trained researcher (IK), supervised by an experienced ASL researcher (HM, 7 years of 
experience). Images that were classified as CBF contrast were used in the perfusion analysis. Images with vascular 
contrast were included in the analysis of spatial CoV, but excluded from the perfusion analysis. The no contrast 
images that contained noise only or large artifacts were excluded from further analysis.
Statistical analysis. For demographic analyses, three groups (frail, pre-frail and non-frail) were compared 
by a one-way ANOVA or chi-square test depending on the type of variable (i.e. continuous or categorical). WMH 
volumes, WMH shape features and cerebral perfusion were compared between the frail and non-frail group and 
between the pre-frail and non-frail group by linear regression analyses adjusting for age and sex. WMH volumes 
were natural log transformed before linear regression analysis and additionally adjusted for intracranial volume 
(ICV). A Pearson’s correlation coefficient was computed to assess the relation between natural log transformed 
total WMH volume and global cerebral gray and white matter perfusion. The presence of lacunar infarcts was 
compared between the frail and non-frail group and between the pre-frail and non-frail group by logistic regres-
sion analyses adjusted for age and sex.
In secondary analyses, WMH shape features were compared between groups by linear regression analy-
ses additionally adjusted for WMH volume, to test if the found associations were WMH volume independent. 
Exploratory post-hoc analyses of the relation between MRI features of SVD (that showed significant between 
group differences) and frailty components were performed by linear regression analyses adjusted for age and sex, 
and for the WMH volume analysis additionally adjusted for ICV. All analyses were performed in SPSS version 25. 
A p-value of below 0.05 was considered statistically significant.
Data Availability
The datasets generated and analyzed during the current study are not publicly available as this is a substudy of a 
still ongoing consortium study, but may be available from the corresponding author on reasonable request
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